Home » Topics » BioWorld Science

BioWorld Science
RSS

ProstaScint may predict response of prostate cancer patients to salvage radiotherapy

Jan. 26, 1998

European alliance formed by Faulding and Asta Medica

Jan. 26, 1998

Two NDAs up for review this week by Cardiovascular and Renal Drugs Advisory Committee

Jan. 26, 1998

Neuroprotective effects of new PARS inhibitor

Jan. 26, 1998

Ortho reveals new fibrinogen receptor antagonists

Jan. 26, 1998

Agents for schizophrenia without EPS disclosed by Warner-Lambert

Jan. 26, 1998

New heterocyclic bradykinin antagonists from Fujisawa

Jan. 26, 1998

Virus-host cell fusion inhibitors under study at Lilly

Jan. 26, 1998

Imidazoles for reversing MDR prepared at Ontogen

Jan. 26, 1998

Dual 5-HT reuptake inhibitors/5-HT1A antagonists developed at Lilly

Jan. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...